Effects of Qingbai Enema on Inflammatory Factors and Adhesion Factors in Patients with Active Ulcerative Colitis

杨磊,李莹,袁星星,李丹丹,王炳予,刘长发,张雅丽
DOI: https://doi.org/10.3969/j.issn.1004-745X.2017.07.005
2017-01-01
Abstract:Objective:To observe the clinical effect of Qingbai Enema in patients with active ulcerative colitis and its influence on serum inflammatory cytokines and adhesion factors.Methods:59 patients with active left colonic ulcerative colitis of accumulated damp-heat type were divided into the control group (29 cases) and the treatment group (30 cases) according to random number table.The control group was treated with Mesalazin enteric-coated tablets and the treatment group was treated with Mesalazin enteric-coated tablets combined with Qingbai Enema;the course of treatment was 6 weeks in both groups.The clinical efficacy,Baron endoscopic score and colon tissue pathology score were observed;ELISA method was used to detect the levels of serum inflammatory factors (IL-1β,TNF-α) and adhesion factors (ICAM-1,VCAM-1).Results:The total effective rate of the treatment group was 93.3%,the control group 82.76%;the difference was statistically significant (P< 0.05).Baron endoscopic score and colon tissue pathology score were improved in the treatment group after treatment (P <0.01),obviously better than the control group (P<0.01).After treatment,the serum IL-1β,TNF-α,ICAM-1 and VCAM-1 were significantly lower in the treatment group (P< 0.01),obviously better than the control group (P<0.01).Conclusion:Qingbai Enema combined with Mesalazin enteric-coated tablets can obviously improve the clinical symptoms,Baron endoscopic score and colon tissue pathology score of patients with active ulcerative colitis of accumulated damp-heat type,down-regulation of the level of IL-1β,TNF-α,ICAM-1 and VCAM-1,with an obvious curative effect.
What problem does this paper attempt to address?